Digestive System Neoplasms: Clinical Trials

8 trials for Digestive System Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 suspended. 8 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Suspended 8
Phase 24Suspended 4

Follow Digestive System Neoplasms: new trials by email Literature Review of Digestive System Neoplasms trials Research Report on Digestive System Neoplasms

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunotherapy for Advanced Liver Cancer
AlloStim® immunotherapy, FOLFOX regimen, Sorafenib - Hepatocellular Carcinoma
Phase 2 / Phase 3SuspendedMirror Biologics, Inc.1502023-08-012025-10-23
Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection
postoperative antimicrobial prophylaxis, No postoperative antimicrobial prophylaxis - Hepatocellular Carcinoma, Postoperative Infection
Phase 3SuspendedSun Yat-sen University4582020-09-012020-03-25
Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC
Nivolumab and TACE/TAE, TACE/TAE - Hepatocellular Carcinoma
Phase 2 / Phase 3SuspendedThe Clatterbridge Cancer Centre NHS Foundation Trust5222019-05-082025-02-26
Acelarin First Line Randomised Pancreatic Study
Acelarin, Gemcitabine - Pancreatic Acinar Carcinoma, Pancreatic Neoplasms
Phase 2 / Phase 3SuspendedThe Clatterbridge Cancer Centre NHS Foundation Trust3282015-12-012019-10-29
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
Rectectomy, Radiotherapy, Capecitabine - Colorectal Neoplasm, Effects of Radiation Therapy
Phase 3SuspendedZhejiang University3502015-10-012022-05-11
Safety and Efficiency of Photodynamic Therapy for Rectal Cancer
Photodynamic therapy - Advanced Rectal Cancer
Phase 2 / Phase 3Suspendedli xiong1002013-08-012013-06-07
L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)
L-Carnitine, Placebo - Pancreatic Carcinoma
Phase 3SuspendedUniversity Medicine Greifswald722006-06-012011-04-07
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Campto, Topotesin, TS-1, L-Plat - Metastatic Colorectal Cancer
Phase 3SuspendedHokkaido Gastrointestinal Cancer Study Group2002006-04-012007-11-01

Narrower conditions

Carcinoma, Hepatocellular (3)  ·  Colorectal Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Fatigue (1)  ·  Liver Neoplasms (1)  ·  Malnutrition (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Radiation Injuries (1)  ·  Rectal Neoplasms (1)

Broader conditions

Digestive System Diseases (8)  ·  Neoplasms by Site (8)  ·  Neoplasms (7)  ·  Adenocarcinoma (3)  ·  Carcinoma (3)  ·  Gastrointestinal Diseases (3)  ·  Gastrointestinal Neoplasms (3)  ·  Intestinal Diseases (3)  ·  Intestinal Neoplasms (3)  ·  Liver Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Rectal Diseases (3)  ·  Colonic Diseases (2)

Interventions

Oxaliplatin (2)  ·  Capecitabine (1)  ·  Carnitine (1)  ·  Fluorouracil (1)  ·  Folfox protocol (1)  ·  Gemcitabine (1)  ·  Irinotecan (1)  ·  Leucovorin (1)  ·  NUC-1031 (1)  ·  Nivolumab (1)  ·  Photochemotherapy (1)  ·  Radiotherapy (1)  ·  S 1 (combination) (1)  ·  Sorafenib (1)  ·  lenvatinib (1)

Sponsors

The Clatterbridge Cancer Centre NHS Foundation Trust (2)  ·  Hokkaido Gastrointestinal Cancer Study Group (1)  ·  Mirror Biologics, Inc. (1)  ·  Sun Yat-sen University (1)  ·  University Medicine Greifswald (1)  ·  Zhejiang University (1)  ·  li xiong (1)

Countries

China (3)  ·  United Kingdom (2)  ·  France (1)  ·  Germany (1)  ·  Japan (1)  ·  Malaysia (1)  ·  Thailand (1)

Top investigators

Daniel H Palmer, BSC, PhD (1)  ·  Daniel Palmer, PhD, MD (1)  ·  Ke-Feng Ding, M.D. (1)  ·  Markus M. Lerch, Prof. (1)  ·  Yoshito Komatsu, MD, PhD (1)

Results publications

PMID 20510306, PMID 32557715, PMID 38181839